Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Wisdom AJ, Yeap BY, Michalski JM, Horick NK, Zietman AL, Christodouleas JP, Kamran SC, Parikh RR, Vapiwala N, Mihalcik S, Miyamoto DT, Zeng J, Gay HA, Pisansky TM, Mishra MV, Spratt DE, Mendenhall NP, Soffen EM, Bekelman JE, Efstathiou JA. Wisdom AJ, et al. Int J Radiat Oncol Biol Phys. 2024 Sep 30:S0360-3016(24)03444-8. doi: 10.1016/j.ijrobp.2024.09.043. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39357788
Reply to Nguyen and Kamrava.
Mouw KW, Wisdom AJ, Schoenfeld JD. Mouw KW, et al. Among authors: wisdom aj. Int J Radiat Oncol Biol Phys. 2024 Sep 1;120(1):302. doi: 10.1016/j.ijrobp.2024.05.007. Int J Radiat Oncol Biol Phys. 2024. PMID: 39147437 No abstract available.
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas.
Su C, Kent CL, Pierpoint M, Floyd W, Luo L, Williams NT, Ma Y, Peng B, Lazarides AL, Subramanian A, Himes JE, Perez VM, Hernansaiz-Ballesteros RD, Roche KE, Modliszewski JL, Selitsky SR, Shinohara ML, Wisdom AJ, Moding EJ, Mowery YM, Kirsch DG. Su C, et al. Among authors: wisdom aj. JCI Insight. 2024 Jun 13;9(14):e178767. doi: 10.1172/jci.insight.178767. JCI Insight. 2024. PMID: 39133651 Free PMC article.
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma.
Su C, Kent CL, Pierpoint M, Floyd W, Luo L, Wiliams NT, Ma Y, Peng B, Lazarides AL, Subramanian A, Himes JE, Perez VM, Hernansaiz-Ballesteros RD, Roche KE, Modliszewski JL, Selitsky SR, Mari Shinohara, Wisdom AJ, Moding EJ, Mowery YM, Kirsch DG. Su C, et al. Among authors: wisdom aj. bioRxiv [Preprint]. 2024 Jan 4:2024.01.03.573968. doi: 10.1101/2024.01.03.573968. bioRxiv. 2024. Update in: JCI Insight. 2024 Jun 13;9(14):e178767. doi: 10.1172/jci.insight.178767 PMID: 38260522 Free PMC article. Updated. Preprint.
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives.
Wisdom AJ, Barker CA, Chang JY, Demaria S, Formenti S, Grassberger C, Gregucci F, Hoppe BS, Kirsch DG, Marciscano AE, Mayadev J, Mouw KW, Palta M, Wu CC, Jabbour SK, Schoenfeld JD. Wisdom AJ, et al. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1404-1421. doi: 10.1016/j.ijrobp.2023.12.046. Epub 2024 Jan 5. Int J Radiat Oncol Biol Phys. 2024. PMID: 38184173 Review.
48 results